Summary. The implantation of Silastic capsules containing androstenedione (release rate 63\m=.\2\ m=+-\ 4\m=.\4 \g=m\g/24h) into 4-day cyclic rats resulted in a prolongation of the cycle (P < 0\m=.\001),most rats showing 5-day cycles after the first, largely unaffected cycle. There was a reduction in ovulation rate (P < 0\m=.\01)and lower serum LH levels on the morning of oestrus (P < 0\m=.\01) but serum FSH levels were unaffected.
Introduction
Androstenedione, a weak androgen, is an important intermediate in the synthesis of oestrogens by the ovary. It is also secreted directly from the ovary as well as from the adrenal gland and serves as a major precursor for peripheral aromatization to oestrogens (Baird, Horton, Longcope & Tait, 1968) , but very little is known about possible direct effects of the steroid on reproductive function. The administration of androstenedione can restore sexual receptivity in ovariectomized, oestrogen-treated, dexamethasone (0-5 mg/kg/day)-suppressed female rhesus monkeys (Everitt & Herbert, 1971) , and elicit daily surges of luteinizing hormone (LH) in ovari¬ ectomized rats (Febres, Seron, Weiner & Siiteri, 1977) . Active immunization of sheep against androstenedione results in an elevation of basal and episodic LH release (Martensz, Baird, Scaramuzzi & Van Look, 1976) and increases ovulation rate (Scaramuzzi, Davidson & Van Look, 1977; Van Look, Clarke, Davidson & Scaramuzzi, 1978) . From these studies it was suggested (Martensz et al, 1976) Serum levels of follicle-stimulating hormone (FSH) and LH were measured by radioimmuno¬ assay using NIAMD-rat-FSH-Il and NIAMD-rat-LH-I3 for iodination and NIAMD-rat-FSH-RP1 and NIAMD-rat-LH-RP 1 as standards. The sensitivity (defined as the amount of standard required to depress binding to 90% of that occurring in the absence of unlabelled hormone) was estimated as 1-0 ± 0-3 ng LH and 1-5 ± 0-5 ng FSH. The intra-and inter-assay coefficients of variation were between 10 and 15% for serum pools (measured amount of LH about 100 ng and FSH about 400 ng) (Welschen et al, 1975 
Results
The effect of androstenedione upon the length of the oestrous cycle is shown in Table 1 . Most control animals continued to show regular 4-day cycles. In rats bearing an androstenedione implant the length of the first oestrous cycle was largely unaffected but thereafter cycles became significantly (P < 0-001) longer, most rats showing a 5-day cycle. This prolongation of the cycle was associated with a significant (P < 0-01) reduction in ovulation rate (Table 2 ). Serum levels of LH were also significantly lower in the experimental animals than in controls (P < 001), but levels of FSH were similar. There was no significant difference in ovarian weight between the two groups. Neill, 1974 , for review), testosterone (Mark & Biskind, 1941) or dehydroepiandrosterone (Ward, Costoff & Mahesh, 1978) since administra¬ tion of these steroids results in suppression of ovulation with either ovarian atrophy (oestrogens, testosterone) or the formation of polycystic ovaries (dehydroepiandrosterone).
The decrease in ovulation rate and serum levels of LH on the morning of oestrus confirms earlier observations (Martensz et al, 1976; Scaramuzzi et al, 1977; Van Look et al, 1978) showing that active immunization of sheep against androstenedione produces the opposite effects, i.e. an increase in ovulation rate and pituitary LH secretion. Since androstenedione treatment of ovariectomized rats (Febres et al, 1977) , sheep (P. F. A. Van Look & R. J. Scaramuzzi, unpublished) and women (Yen, Vandenberg, Tsai & Parker, 1974) has no effect on the elevated tonic secretion of LH, it seems likely that the lower LH levels observed in the rats with an androstenedione implant are the result of a permissive action of the administered hormone on the negative-feedback effect exerted by endogenous oestrogen in these animals (Martensz et al, 1976 ). The exact site at which androstenedione exerts this effect is uncertain. It has been shown that the hypothalamus has the capacity to convert androstenedione to oestrone (Reddy, Naftolin & Ryan, 1974) and that implantation of oestrogen in the median eminence region lowers tissue content of LH-RH and plasma levels of LH (Chowers & McCann, 1965) . Alternatively, androstenedione may influence gonadotrophin secretion directly through an action on the pituitary gonadotrophs. Drouin & Labrie (1976) have demonstrated that addition of androstenedione to rat pituitary cells in culture reduces the secretion of LH in response to LH-RH. The absence of a decrease in serum levels of FSH in the animals treated with andro¬ stenedione may be related to the greater sensitivity of LH release than of FSH release to androgens (Swerdloff, Walsh & Odell, 1972) . The increase in cycle length in androstenedionetreated rats was associated with a significant decrease in ovulation rate. It is unlikely that this reduced ovulation rate is a direct consequence of the increase in cycle length per se since the ovulation rate in spontaneous 5-day cyclic rats is similar to that in 4-day cyclic rats in our colony of animals. The mechanism underlying this decreased ovulation rate is uncertain. The stimulus for ovulation may be inadequate as a result of the central effect of the steroid. Alternatively, the reduction of ovulation rate may be due to a reduction in the number of pre¬ ovulatory follicles, since androgens have been shown to induce follicular atresia through a direct action on the ovary (Louvet, Harman, Schreiber & Ross, 1975 
